Pinnacle Bancorp Inc. Has $1.14 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Pinnacle Bancorp Inc. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,248 shares of the healthcare conglomerate’s stock after purchasing an additional 51 shares during the quarter. Pinnacle Bancorp Inc.’s holdings in UnitedHealth Group were worth $1,137,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in the stock. Websterrogers Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $223,000. Armstrong Advisory Group Inc. raised its holdings in shares of UnitedHealth Group by 2.3% in the fourth quarter. Armstrong Advisory Group Inc. now owns 2,060 shares of the healthcare conglomerate’s stock valued at $1,042,000 after purchasing an additional 47 shares during the last quarter. Rockingstone Advisors LLC boosted its holdings in UnitedHealth Group by 426.4% during the fourth quarter. Rockingstone Advisors LLC now owns 2,616 shares of the healthcare conglomerate’s stock worth $1,323,000 after purchasing an additional 2,119 shares during the last quarter. ARS Wealth Advisors Group LLC increased its stake in UnitedHealth Group by 0.6% in the 4th quarter. ARS Wealth Advisors Group LLC now owns 27,646 shares of the healthcare conglomerate’s stock valued at $13,985,000 after buying an additional 165 shares during the last quarter. Finally, Wiser Wealth Management Inc boosted its stake in shares of UnitedHealth Group by 14.5% during the 4th quarter. Wiser Wealth Management Inc now owns 482 shares of the healthcare conglomerate’s stock worth $244,000 after buying an additional 61 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $543.21 on Thursday. The company has a market cap of $499.91 billion, a price-to-earnings ratio of 35.39, a PEG ratio of 1.42 and a beta of 0.62. The stock has a fifty day moving average price of $554.45 and a 200-day moving average price of $563.12. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the previous year, the company earned $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Analyst Upgrades and Downgrades

Several brokerages recently commented on UNH. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Oppenheimer raised their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Finally, Barclays boosted their target price on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and three have given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $626.79.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.